Xenogeneic cell-based medicinal products - Scientific guideline
HumanAdvanced therapiesScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document addresses the scientific requirements for medicinal products that contain viable animal cells or tissues as an active substance (xenogeneic cell-based medicinal products). It provides general principles for the development and assessment of xenogeneic cell-based products without prejudice to medical practice or national legislation, which may be applicable.
Keywords: Xenogeneic, cell therapy, quality, nonclinical, clinical, transgenic animals